Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongluo Qutong Ointment vs diclofenac patch for cervical radiculopathy pain
ChiCTR2100050354Phase 4Not yet recruiting
- Sponsor
- Gansu Second Provincial People's Hospital
- Start
- Apr 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Tongluo Qutong in cervical spondylotic radiculopathy (CSR) (2 arms), sponsored by Gansu Second Provincial People's Hospital. Primary endpoints: Change in pain VAS score from baseline at day 7, Reduction rate of pain VAS score compared with baseline and 6 more. Planned start Apr 2021; status: not yet recruiting.
02
Drugs
Tongluo Qutong
03
Conditions
cervical spondylotic radiculopathy (CSR)
Beyond the preview
Go deeper on ChiCTR2100050354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050354.